📰New & Featured | A study in #Cell introduces a new #macrophage-targeted #immunocytokine (#MiTE) reprograms #TREM2⁺ TAMs and locally activates #T/NK cells, delivering strong #anti-tumor immunity without #IL-2 toxicity.
🌟Opens up new path to overcome #immunosuppression.

Fapon Biopharma to Exhibit Innovative Platforms and Pipeline at BIO 2025 Fapon Biopharma announces its participation in BIO 2025, showcasing groundbreaking therapies including Phase 1 immunocytokine FP008 and innovative technologies.

Fapon Biopharma to Exhibit Innovative Platforms and Pipeline at BIO 2025 #United_States #Boston #Fapon_Biopharma #FP008 #Immunocytokine